Hygienic assessment of the impact of N-nitrosamines in their total intake into the body of young children
- Authors: Suvorov D.V.1, Zaitseva N.V.1, Shur P.Z.1, Zemlyanova M.A.1
-
Affiliations:
- Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
- Issue: Vol 104, No 6 (2025)
- Pages: 755-760
- Section: FOOD HYGIENE
- Published: 15.12.2025
- URL: https://rjpbr.com/0016-9900/article/view/691565
- DOI: https://doi.org/10.47470/0016-9900-2025-104-6-755-760
- EDN: https://elibrary.ru/bwhyfh
- ID: 691565
Cite item
Abstract
Introduction. N-nitrosamines are priority potentially hazardous contaminants occurring in some food products; they pose a considerable threat for health in infants and toddlers. The valid standards substantiated per levels of carcinogenic risk regulate contents of two such compounds. However, it is necessary to accomplish complex assessment of impacts exerted by all identified N-nitrosamines at lower doses considering their non-carcinogenic effects. This will provide a more comprehensive approach to assessing risks associated with their intake with food products.The aim of the study was to assess the impact of N-nitrosamines at their total intake with canned meat in infants and toddlers.Materials and methods. The study involved Wistar rats (aged 4–8 weeks). The experiment animals were divided into a control group (standard fodder) and two test groups (canned meat). We estimated biochemical blood indices (AST, ALT, GGT, bilirubin, alkaline phosphatase) and histological state of the liver, dose-dependent effects. Statistical analysis included the Mann – Whitney U-test and regression analysis.Results. After a 28-day experiment, levels of biochemical indices turned out to be significantly higher in the test groups against the control (p < 0.05). Regression analysis confirmed an association between levels of exposure to N-nitrosamines and elevated levels of biomarkers of effect (R2 for GGT = 0.725, p < 0.000001). Histology of the liver found a growing number of Kupffer cells (p < 0.05), which are markers of inflammatory response. We established model parameters for describing a relationship between likelihood of increased markers of the effect and the total dose of N-nitrosamines. Tolerable daily intake (TDI) was determined based on the study findings; it was equal to 0.00175 µg/kg of body weight, ensuring safety, taking into account the carcinogenic risk criterion.Limitations. The obtained results are applicable exclusively to canned meat for infants and toddlers and cannot be extrapolated onto other food products or age groups. Conclusion. The experiment results obtained by using markers of effects were also confirmed by histological studies. This indicates that the established regression parameters and TDI can be employed in quantification of health risks for infants and toddlers considering non-carcinogenic effects. Compliance with ethical standards. The study was approved by the local ethics committee of the Rospotrebnadzor’s (Meeting Report No. 2 dated February 20, 2018) and conducted in conformity with the conventional research principles stated in the WMA Declaration of Helsinki (as of edited in 2013).Contribution: Suvorov D.V. – concept and design of the study, collection of literature data, statistical analysis, writing text; Zaitseva N.V., Shur P.Z., Zemlyanova M.A. – concept of the study, editing. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.Conflict of interest. The authors declare no conflict of interest.Funding. The study had no sponsorship.Received: April 3, 2025 / Revised: May 19, 2025 / Accepted: June 26, 2025 / Published: July 31, 2025
About the authors
Dmitri V. Suvorov
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
Email: suvorov@fcrisk.ru
ORCID iD: 0000-0002-3594-2650
Nina V. Zaitseva
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
Email: znv@fcrisk.ru
ORCID iD: 0000-0003-2356-1145
Pavel Z. Shur
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
Email: shur@fcrisk.ru
ORCID iD: 0000-0001-5171-3105
Marina A. Zemlyanova
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
Email: zem@fcrisk.ru
ORCID iD: 0000-0002-8013-9613
References
Суворов Д.В., Зайцева Н.В., Шур П.З., Зеленкин С.Е., Нго Н.Т.Х., Тхан Т.Т. Оценка риска для здоровья, связанного с содержанием приоритетных потенциально опасных компонентов, выявленных в мясных и мясорастительных консервах, предназначенных для питания детей раннего возраста. Вопросы питания. 2023; 92(4): 38–48. https://doi.org/10.33029/0042-8833-2023-92-4-38-48 https://elibrary.ru/dqdufj Бережанская С.Б., Лукьянова Е.А., Каушанская Е.Я., Ищенко Е.В. Динамика морфофункциональных нарушений печени у детей, перенесших перинатальную гипоксию, на протяжении первого года жизни. Педиатрия им. Г.Н. Сперанского. 2013; 92(2): 52–6. https://elibrary.ru/qikjzb Зобнин Ю.В. Токсическое повреждение печени у детей. Сибирский медицинский журнал (Иркутск). 2017; 151(4): 37–53. https://elibrary.ru/waoyot Schrenk D., Bignami M., Bodin L., Chipman J.K., del Mazo J., Hogstrand C., et al. Scientific Opinion on the risk assessment of N-nitrosamines in food. EFSA Journal. 2023; 21(3): 7884. https://doi.org/10.2903/j.efsa.2023.7884 European Food Safety Authority. Nitrosamines in food raise a health concern; 2023. Available at: https://efsa.europa.eu/en/news/nitrosamines-food-raise-health-concern Liu W., Huang J., Yan Z., Lin Y., Huang G., Chen X., et al. Association of N-nitrosodimethylamine exposure with cognitive impairment based on the clues of mice and humans. Front. Aging Neurosci. 2023; 15: 1137164. https://doi.org/10.3389/fnagi.2023.1137164 Масловская А.А. Особенности энергетического обмена у детей. Журнал Гродненского государственного медицинского университета. 2006; (1): 25–8. https://elibrary.ru/qbfivd ATSDR. Toxicological profile for N-nitrosodimethylamine. Atlanta; 2023. George J., Ramesh Rao K., Stern R., Chandrakasan G. Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology. 2001; 156(2–3): 129–38. https://doi.org/10.1016/s0300-483x(00)00352-8 Patterson J., Boateng J., Walker L.T., Verghese M. Cytotoxic effects of multiple n-nitrosamines in human liver cell line Hep2G: possible mechanisms of action. J. Pharmacol. Toxicol. 2012; 7(3): 114–27. Боев В.М. Методология комплексной оценки антропогенных и социально-экономических факторов в формировании риска для здоровья населения. Гигиена и санитария. 2009; (4): 4–8. https://elibrary.ru/kwuenz Zhang H., Lu L., Zhao C., Liu Q., Zhou Q., Zhang Y., et al. Lipid metabolism disorders contribute to hepatotoxicity of ICR mice induced by nitrosamines exposure. Environ. Int. 2022; 167: 107423. https://doi.org/10.1016/j.envint.2022.107423 U.S. Food and Drug Administration. Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs). Guidance for Industry; 2023. Зайцева Н.В., Чан Тао Шон, Буи Тао Тиен, Уланова Т.С., Нурисламова Т.В., Мальцева О.А. Сравнительная оценка результатов исследования контаминации N-нитрозоаминами консервированных мясорастительных продуктов для детского питания разными методами в России и во Вьетнаме. Вопросы питания. 2019; 88(5): 93–102. https://doi.org/10.24411/0042-8833-2019-10058 https://elibrary.ru/lqnhya Зайцева Н.В., Уланова Т.С., Нурисламова Т.В., Попова Н.А., Мальцева О.А. Идентификация и количественное хромато-масс-спектрометрическое определение токсичных химических соединений (N-нитрозоамины, фталаты) в пищевых продуктах для детского питания. Вопросы питания. 2022; 91(3): 107–14. https://doi.org/10.33029/0042-8833-2022-91-3-107-114 https://elibrary.ru/twnmod More S.J., Bampidis V., Benford D., Bragard C., Halldorsson T.I., Hernández-Jerez A.F., et al. Guidance on the use of the benchmark dose approach in risk assessment. EFSA Journal. 2022; 20(10): e07584. https://doi.org/10.2903/j.efsa.2022.7584 Суворов Д.В., Шур П.З., Зеленкин С.Е. К вопросу об определении допустимой суточной дозы суммы N-нитрозоаминов для детей раннего возраста. Анализ риска здоровью. 2024; (4): 72–80. https://doi.org/10.21668/health.risk/2024.4.07 https://elibrary.ru/yuejfa Котеров А.Н., Ушенкова Л.Н., Зубенкова Э.С., Вайнсон А.А., Бирюков А.П. Соотношение возрастов основных лабораторных животных (мышей, крыс, хомячков и собак) и человека: актуальность для проблемы возрастной радиочувствительности и анализ опубликованных данных. Медицинская радиология и радиационная безопасность. 2018; 63(1): 5–27. https://doi.org/10.12737/article_5a82e4a3908213.56647014 https://elibrary.ru/ytgihj Шур П.З., Суворов Д.В., Землянова М.А., Нурисламова Т.В. Экспериментальное обоснование параметров токсичности N-нитрозоаминов при поступлении с пищевыми продуктами для детей раннего возраста по критериям риска здоровью. Гигиена и санитария. 2020; 99(8): 848–53. https://doi.org/10.47470/0016-9900-2020-99-8-848-853 https://elibrary.ru/tdtcpj Usunomena U., Joshua A.A., Okugbo O.T., Evuen U.F., Osibemhe M., Okolie N.P. N-nitrosodimethylamine (NDMA), liver function enzymes, renal function parameters and oxidative stress parameters: a review. Br. J. Pharmacol. Toxicol. 2012; 3(4): 165–76. Lathouri M., Korre A., Dusinska M., Durucan S. Human Health Hazard Assessment Strategy for Amine Emissions Around PCC Facilities. Deliverable D3.3. Trondheim: SCOPE; 2022. Roszczenko A., Jablonski J., Moniuszko-Jakoniuk J. Effect of N-nitrosodimethylamine (NDMA) on activity of selected enzymes in blood serum of the rat. Med. Pr. 1996; 47(1): 49–53. Moniuszko-Jakoniuk J., Roszczenko A., Dzieciol J. Influence of low concentrations of N-nitrosodimethylamine on the iron level and histopathological picture of rats liver, spleen and bone marrow. Acta Pol. Toxicol. 1999; 7(2): 179–86. Цыркунов В.М., Андреев В.П., Кравчук Р.И., Прокопчик Н.И. Клиническая цитология печени: клетки Купфера. Журнал Гродненского государственного медицинского университета. 2017; 15(4): 419–31. https://doi.org/10.25298/2221-8785-2017-15-4-419-431 https://elibrary.ru/zrktdz Wheeler M.D. Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res. Health. 2003; 27(4): 300–6. Dixon L.J., Barnes M., Tang H., Pritchard M.T., Nagy L.E. Kupffer cells in the liver. Compr. Physiol. 2013; 3(2): 785–97. https://doi.org/10.1002/cphy.c120026 Kolios G., Valatas V., Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J. Gastroenterol. 2006; 12(46): 7413–20. https://doi.org/10.3748/wjg.v12.i46.7413 Seki E., Schwabe R.F. Hepatic inflammation and fibrosis: Functional links and key pathways. Hepatology. 2015; 61(3): 1066–79. https://doi.org/10.1002/hep.27332
Supplementary files
